BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15300884)

  • 1. Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studies.
    Slifstein M; Narendran R; Hwang DR; Sudo Y; Talbot PS; Huang Y; Laruelle M
    Synapse; 2004 Oct; 54(1):46-63. PubMed ID: 15300884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET.
    Mukherjee J; Christian BT; Narayanan TK; Shi B; Collins D
    Brain Res; 2005 Jan; 1032(1-2):77-84. PubMed ID: 15680944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates.
    Slifstein M; Hwang DR; Huang Y; Guo N; Sudo Y; Narendran R; Talbot P; Laruelle M
    Psychopharmacology (Berl); 2004 Sep; 175(3):274-86. PubMed ID: 15024551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans.
    Cropley VL; Innis RB; Nathan PJ; Brown AK; Sangare JL; Lerner A; Ryu YH; Sprague KE; Pike VW; Fujita M
    Synapse; 2008 Jun; 62(6):399-408. PubMed ID: 18361438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
    Narendran R; Frankle WG; Mason NS; Rabiner EA; Gunn RN; Searle GE; Vora S; Litschge M; Kendro S; Cooper TB; Mathis CA; Laruelle M
    Synapse; 2009 Jun; 63(6):447-61. PubMed ID: 19217025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride.
    Mukherjee J; Yang ZY; Brown T; Lew R; Wernick M; Ouyang X; Yasillo N; Chen CT; Mintzer R; Cooper M
    Nucl Med Biol; 1999 Jul; 26(5):519-27. PubMed ID: 10473190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride.
    Kegeles LS; Slifstein M; Frankle WG; Xu X; Hackett E; Bae SA; Gonzales R; Kim JH; Alvarez B; Gil R; Laruelle M; Abi-Dargham A
    Neuropsychopharmacology; 2008 Dec; 33(13):3111-25. PubMed ID: 18418366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
    Abi-Dargham A; Simpson N; Kegeles L; Parsey R; Hwang DR; Anjilvel S; Zea-Ponce Y; Lombardo I; Van Heertum R; Mann JJ; Foged C; Halldin C; Laruelle M
    Synapse; 1999 May; 32(2):93-109. PubMed ID: 10231129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.
    Mukherjee J; Christian BT; Dunigan KA; Shi B; Narayanan TK; Satter M; Mantil J
    Synapse; 2002 Dec; 46(3):170-88. PubMed ID: 12325044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans.
    Riccardi P; Li R; Ansari MS; Zald D; Park S; Dawant B; Anderson S; Doop M; Woodward N; Schoenberg E; Schmidt D; Baldwin R; Kessler R
    Neuropsychopharmacology; 2006 May; 31(5):1016-26. PubMed ID: 16237395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouse.
    Rominger A; Wagner E; Mille E; Böning G; Esmaeilzadeh M; Wängler B; Gildehaus FJ; Nowak S; Bruche A; Tatsch K; Bartenstein P; Cumming P
    Synapse; 2010 Apr; 64(4):313-22. PubMed ID: 19957365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal and extrastriatal dopamine release measured with PET and [(18)F] fallypride.
    Slifstein M; Kegeles LS; Xu X; Thompson JL; Urban N; Castrillon J; Hackett E; Bae SA; Laruelle M; Abi-Dargham A
    Synapse; 2010 May; 64(5):350-62. PubMed ID: 20029833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [¹⁸F]fallypride and [¹⁸F]desmethoxyfallypride.
    Constantinescu CC; Coleman RA; Pan ML; Mukherjee J
    Synapse; 2011 Aug; 65(8):778-87. PubMed ID: 21218455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in amphetamine-induced displacement of [(18)F]fallypride in striatal and extrastriatal regions: a PET study.
    Riccardi P; Zald D; Li R; Park S; Ansari MS; Dawant B; Anderson S; Woodward N; Schmidt D; Baldwin R; Kessler R
    Am J Psychiatry; 2006 Sep; 163(9):1639-41. PubMed ID: 16946193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of dopamine D-2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride.
    Mukherjee J; Christian BT; Narayanan TK; Shi B; Mantil J
    Neuropsychopharmacology; 2001 Oct; 25(4):476-88. PubMed ID: 11557161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.
    Vandehey NT; Moirano JM; Converse AK; Holden JE; Mukherjee J; Murali D; Nickles RJ; Davidson RJ; Schneider ML; Christian BT
    J Cereb Blood Flow Metab; 2010 May; 30(5):994-1007. PubMed ID: 20040928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized in vivo detection of dopamine release using 18F-fallypride PET.
    Ceccarini J; Vrieze E; Koole M; Muylle T; Bormans G; Claes S; Van Laere K
    J Nucl Med; 2012 Oct; 53(10):1565-72. PubMed ID: 22933820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study.
    Chou YH; Halldin C; Farde L
    Synapse; 2000 Nov; 38(2):138-43. PubMed ID: 11018787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring the in vivo binding parameters of [18F]-fallypride in monkeys using a PET multiple-injection protocol.
    Christian BT; Narayanan T; Shi B; Morris ED; Mantil J; Mukherjee J
    J Cereb Blood Flow Metab; 2004 Mar; 24(3):309-22. PubMed ID: 15091112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surrogate markers for cerebral blood flow correlate with [¹⁸F]-fallypride binding potential at dopamine D(2/3) receptors in human striatum.
    Cumming P; Xiong G; la Fougère C; Rominger A; Bartenstein P; Buchholz HG; Piel M; Rösch F; Gründer G; Vernaleken I
    Synapse; 2013 Apr; 67(4):199-203. PubMed ID: 23239525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.